Skip to content

A Study of Blood Cells Count in 6 Months to 18 Years Old Patients

A Study Of Clinico-Haematological Profile and Etiology Of Pancytopenia / Bicytopenia In Pediatric Age Group From 6 Months To 18 Years - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/12/060609
Enrollment
75
Registered
2023-12-21
Start date
Unknown
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D50-D89- Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

Dr Kaushal Vasudev Vanjani
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All children in the age group of 6 months to 18 years and who had Pancytopenia defined as Hb <10 gm%, WBC <4000/mm3 , Platelet count <1lac/mm3 OR Bicytopenia defined as any reduction in any two cell lineages, were included.

Exclusion criteria

Exclusion criteria: All patients aged less than 6 months & more than 18 years. Diagnosed cases of aplastic anaemia and leukaemia, clinical suspicion of genetic, or constitutional pancytopenia. Patients with history of blood transfusion. Patient guardians who do not give consent for study.

Design outcomes

Primary

MeasureTime frame
1)To identify the clinical presentations in patients with pancytopenia/bicytopenia. 2)To evaluate hematological parameters in patients with pancytopenia/bicytopenia. 3)To identify the etiology in patients with cytopenias. Timepoint: 2 weeks,4 weeks,6 weeks,8 weeks

Secondary

MeasureTime frame
Not ApplicableTimepoint: Not Applicable

Countries

India

Contacts

Public ContactDr Kaushal Vasudev Vanjani

Varun Arjun Medical College and Rohilkhand Hospital

drajaysood78@gmail.com9335038479

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026